A detailed history of Carmignac Gestion transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Carmignac Gestion holds 55,262 shares of TMO stock, worth $29 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
55,262
Previous 81,753 32.4%
Holding current value
$29 Million
Previous $45.2 Million 24.39%
% of portfolio
0.59%
Previous 0.79%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$531.86 - $624.21 $14.1 Million - $16.5 Million
-26,491 Reduced 32.4%
55,262 $34.2 Million
Q2 2024

Aug 13, 2024

BUY
$541.52 - $599.02 $7.62 Million - $8.43 Million
14,067 Added 20.78%
81,753 $45.2 Million
Q1 2024

May 14, 2024

SELL
$528.82 - $599.43 $3.42 Million - $3.88 Million
-6,472 Reduced 8.73%
67,686 $39.3 Million
Q4 2023

Feb 13, 2024

SELL
$431.41 - $532.94 $67.4 Million - $83.3 Million
-156,342 Reduced 67.83%
74,158 $39.4 Million
Q3 2023

Nov 13, 2023

BUY
$498.29 - $574.41 $83.4 Million - $96.1 Million
167,296 Added 264.69%
230,500 $117 Million
Q2 2023

Aug 11, 2023

BUY
$508.46 - $591.13 $13.6 Million - $15.8 Million
26,692 Added 73.1%
63,204 $33 Million
Q1 2023

May 12, 2023

BUY
$535.0 - $604.82 $1.33 Million - $1.5 Million
2,488 Added 7.31%
36,512 $21 Million
Q4 2022

Feb 13, 2023

BUY
$484.71 - $571.37 $137,657 - $162,269
284 Added 0.84%
34,024 $18.7 Million
Q3 2022

Nov 10, 2022

SELL
$507.19 - $604.49 $732,382 - $872,883
-1,444 Reduced 4.1%
33,740 $17.2 Million
Q2 2022

Aug 12, 2022

SELL
$500.9 - $612.21 $2.12 Million - $2.59 Million
-4,224 Reduced 10.72%
35,184 $19.1 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $501,468 - $617,188
957 Added 2.49%
39,408 $23.3 Million
Q4 2021

Feb 11, 2022

BUY
$569.0 - $667.24 $4.92 Million - $5.77 Million
8,651 Added 29.03%
38,451 $25.6 Million
Q3 2021

Nov 12, 2021

BUY
$509.53 - $609.78 $1.11 Million - $1.32 Million
2,170 Added 7.85%
29,800 $17.1 Million
Q2 2021

Aug 13, 2021

BUY
$441.0 - $508.24 $529,641 - $610,396
1,201 Added 4.54%
27,630 $13.9 Million
Q1 2021

May 14, 2021

BUY
$439.85 - $518.83 $811,083 - $956,722
1,844 Added 7.5%
26,429 $12 Million
Q4 2020

Feb 12, 2021

SELL
$435.06 - $527.66 $120,511 - $146,161
-277 Reduced 1.11%
24,585 $11.4 Million
Q3 2020

Nov 13, 2020

SELL
$359.77 - $441.52 $225,575 - $276,833
-627 Reduced 2.46%
24,862 $11 Million
Q2 2020

Aug 13, 2020

SELL
$275.2 - $362.34 $69.7 Million - $91.7 Million
-253,121 Reduced 90.85%
25,489 $9.23 Million
Q1 2020

May 14, 2020

SELL
$255.3 - $340.05 $65.3 Million - $87 Million
-255,841 Reduced 47.87%
278,610 $79 Million
Q4 2019

Feb 13, 2020

BUY
$271.93 - $328.04 $32.1 Million - $38.7 Million
117,962 Added 28.32%
534,451 $174 Million
Q3 2019

Nov 13, 2019

BUY
$268.46 - $305.43 $112 Million - $127 Million
415,443 Added 39717.3%
416,489 $121 Million
Q2 2019

Aug 13, 2019

BUY
$257.51 - $295.55 $269,355 - $309,145
1,046 New
1,046 $307,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $205B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Carmignac Gestion Portfolio

Follow Carmignac Gestion and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

News

Stay updated on Carmignac Gestion with notifications on news.